432 related articles for article (PubMed ID: 8826969)
21. ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies.
Miao D; Yu L; Tiberti C; Cuthbertson DD; Rewers M; di Mario U; Eisenbarth GS; Dotta F
J Autoimmun; 2002 Mar; 18(2):191-6. PubMed ID: 11908951
[TBL] [Abstract][Full Text] [Related]
22. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus.
Lan MS; Wasserfall C; Maclaren NK; Notkins AL
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6367-70. PubMed ID: 8692821
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
24. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies to IA-2 in insulin-dependent diabetes mellitus. Measurements with a new immunoprecipitation assay.
Masuda M; Powell M; Chen S; Beer C; Fichna P; Rees Smith B; Furmaniak J
Clin Chim Acta; 2000 Jan; 291(1):53-66. PubMed ID: 10612717
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of ICA512As in combination with other islet cell autoantibodies at the onset of IDDM.
Feeney SJ; Myers MA; Mackay IR; Zimmet PZ; Howard N; Verge CF; Rowley MJ
Diabetes Care; 1997 Sep; 20(9):1403-7. PubMed ID: 9283787
[TBL] [Abstract][Full Text] [Related]
27. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
[TBL] [Abstract][Full Text] [Related]
28. Dual-parameter model for prediction of type I diabetes mellitus.
Eisenbarth GS; Gianani R; Yu L; Pietropaolo M; Verge CF; Chase HP; Redondo MJ; Colman P; Harrison L; Jackson R
Proc Assoc Am Physicians; 1998; 110(2):126-35. PubMed ID: 9542768
[TBL] [Abstract][Full Text] [Related]
29. Autoantibodies to IA-2 not detected in NOD mice or BB rats.
DeSilva MG; Jun HS; Yoon JW; Notkins AL; Lan MS
Diabetologia; 1996 Oct; 39(10):1237-8. PubMed ID: 8897014
[No Abstract] [Full Text] [Related]
30. A novel high-throughput method for accurate, rapid, and economical measurement of multiple type 1 diabetes autoantibodies.
Woo W; LaGasse JM; Zhou Z; Patel R; Palmer JP; Campus H; Hagopian WA
J Immunol Methods; 2000 Oct; 244(1-2):91-103. PubMed ID: 11033022
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.
Winnock F; Christie MR; Batstra MR; Aanstoot HJ; Weets I; Decochez K; Jopart P; Nicolaij D; Gorus FK;
Diabetes Care; 2001 Jul; 24(7):1181-6. PubMed ID: 11423499
[TBL] [Abstract][Full Text] [Related]
32. Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes.
Hawa M; Rowe R; Lan MS; Notkins AL; Pozzilli P; Christie MR; Leslie RD
Diabetes; 1997 Aug; 46(8):1270-5. PubMed ID: 9231650
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to SOX13 (ICA12) are associated with type 1 diabetes.
Kasimiotis H; Fida S; Rowley MJ; Mackay IR; Zimmet PZ; Gleason S; Rabin DU; Myers MA
Autoimmunity; 2001; 33(2):95-101. PubMed ID: 11264788
[TBL] [Abstract][Full Text] [Related]
34. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
Knip M; Karjalainen J; Akerblom HK
Diabetes Care; 1998 Oct; 21(10):1670-3. PubMed ID: 9773728
[TBL] [Abstract][Full Text] [Related]
35. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
[TBL] [Abstract][Full Text] [Related]
36. Novel fusion proteins in the analysis of diabetes-associated autoantibodies to GAD65 and IA-2.
Zavialov A; Ankelo M; Westerlund-Karlsson A; Knip M; Ilonen J; Hinkkanen A
J Immunol Methods; 2000 Dec; 246(1-2):91-6. PubMed ID: 11121550
[TBL] [Abstract][Full Text] [Related]
37. Islet cell antibodies represent autoimmune response against several antigens.
Månsson L; Törn C; Landin-Olsson M
Int J Exp Diabetes Res; 2001; 2(2):85-90. PubMed ID: 12369720
[TBL] [Abstract][Full Text] [Related]
38. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
Seissler J; Atik Y; Klinghammer A; Scherbaum WA
Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
[TBL] [Abstract][Full Text] [Related]
39. Autoantibody against ICA512 did not improve test sensitivity for slowly progressive IDDM in adults.
Kasuga A; Ozawa Y; Maruyama T; Ishihara T; Amemiya S; Saruta T
Diabetes Care; 1997 Apr; 20(4):679-80. PubMed ID: 9097008
[No Abstract] [Full Text] [Related]
40. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.
Wiest-Ladenburger U; Hartmann R; Hartmann U; Berling K; Böhm BO; Richter W
Diabetes; 1997 Apr; 46(4):565-71. PubMed ID: 9075795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
